Literature DB >> 3300423

Postoperative analgesia induced by subarachnoid lidocaine plus calcitonin.

F S Miralles, F Lopez-Soriano, M M Puig, D Perez, F Lopez-Rodriguez.   

Abstract

A randomized double-blind study tested the analgesic effects of subarachnoid administration of salmon calcitonin (sCT) in acute postoperative pain. Sixty patients were grouped according to type of surgery (intraabdominal, extraabdominal, and lower extremities), subdivided into those given subarachnoid lidocaine 1 mg/kg plus sCT (100 IU) or lidocaine plus saline. Pain was evaluated by a descriptive scale 3, 6, 12, 24, 48, and 72 hr after surgery, as well as by the frequency of the patients' requests for postoperative analgesics. In all instances, the sCT-treated patients had significantly less postoperative pain. Similarly, the requests for analgesics was significantly lower or absent in the sCT-treated group. Minor side effects such as nausea and vomiting, abdominal pain, and "nervousness" were observed in a small number of sCT-treated patients. In our series of 30 patients, subarachnoid administration of sCT was an effective analgesic with minimal side effects. Its safety remains to be proved by further studies.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3300423

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  6 in total

Review 1.  The epidural and intrathecal administration of somatotrophin-release inhibiting factor: native and synthetic analogues.

Authors:  D P Beltrutti; S Moessinger; G Varrassi
Journal:  Curr Rev Pain       Date:  2000

2.  25 years of salmon calcitonin: from synthesis to therapeutic use.

Authors:  M Azria; D H Copp; J M Zanelli
Journal:  Calcif Tissue Int       Date:  1995-12       Impact factor: 4.333

3.  [Calcitonin.].

Authors:  C Maier
Journal:  Schmerz       Date:  1990-03       Impact factor: 1.107

4.  Analgesic effect of salmon calcitonin in osteoporotic vertebral fractures: a double-blind placebo-controlled clinical study.

Authors:  G P Lyritis; N Tsakalakos; B Magiasis; T Karachalios; A Yiatzides; M Tsekoura
Journal:  Calcif Tissue Int       Date:  1991-12       Impact factor: 4.333

5.  Oral calcitonin.

Authors:  Ronald C Hamdy; Dane N Daley
Journal:  Int J Womens Health       Date:  2012-09-06

6.  Clinical efficacy of calcitonin compared to diclofenac sodium in chronic nonspecific low back pain with type I Modic changes: a retrospective study.

Authors:  Jiaming Zhou; Tengshuai Li; Liandong Li; Yuan Xue
Journal:  J Pain Res       Date:  2018-07-17       Impact factor: 3.133

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.